These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12815663)

  • 1. Essential tremor is not associated with alpha-synuclein gene haplotypes.
    Pigullo S; Di Maria E; Marchese R; Bellone E; Gulli R; Scaglione C; Battaglia S; Barone P; Martinelli P; Abbruzzese G; Ajmar F; Mandich P
    Mov Disord; 2003 Jul; 18(7):823-6. PubMed ID: 12815663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy.
    Spadafora P; Annesi G; Pasqua AA; Serra P; Cirò Candiano IC; Carrideo S; Tarantino P; Civitelli D; De Marco EV; Nicoletti G; Annesi F; Quattrone A
    Neurosci Lett; 2003 Nov; 351(2):75-8. PubMed ID: 14583385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor?
    Tan EK; Matsuura T; Nagamitsu S; Khajavi M; Jankovic J; Ashizawa T
    Neurology; 2000 Mar; 54(5):1195-8. PubMed ID: 10720300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australian data and meta-analysis lend support for alpha-synuclein (NACP-Rep1) as a risk factor for Parkinson's disease.
    Mellick GD; Maraganore DM; Silburn PA
    Neurosci Lett; 2005 Feb; 375(2):112-6. PubMed ID: 15670652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan.
    Izumi Y; Morino H; Oda M; Maruyama H; Udaka F; Kameyama M; Nakamura S; Kawakami H
    Neurosci Lett; 2001 Mar; 300(2):125-7. PubMed ID: 11207390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-synuclein haplotypes implicated in risk of Parkinson's disease.
    Tan EK; Chai A; Teo YY; Zhao Y; Tan C; Shen H; Chandran VR; Teoh ML; Yih Y; Pavanni R; Wong MC; Puvan K; Lo YL; Yap E
    Neurology; 2004 Jan; 62(1):128-31. PubMed ID: 14718715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the coding and the 5' flanking regions of the alpha-synuclein gene in patients with Parkinson's disease.
    Pastor P; Muñoz E; Ezquerra M; Obach V; Martí MJ; Valldeoriola F; Tolosa E; Oliva R
    Mov Disord; 2001 Nov; 16(6):1115-9. PubMed ID: 11748744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Synuclein gene haplotypes are associated with Parkinson's disease.
    Farrer M; Maraganore DM; Lockhart P; Singleton A; Lesnick TG; de Andrade M; West A; de Silva R; Hardy J; Hernandez D
    Hum Mol Genet; 2001 Aug; 10(17):1847-51. PubMed ID: 11532993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system.
    Chiba-Falek O; Nussbaum RL
    Hum Mol Genet; 2001 Dec; 10(26):3101-9. PubMed ID: 11751692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the alpha-synuclein promoter: expression analyses and association studies in Parkinson's disease.
    Holzmann C; Krüger R; Saecker AM; Schmitt I; Schöls L; Berger K; Riess O
    J Neural Transm (Vienna); 2003 Jan; 110(1):67-76. PubMed ID: 12541013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability.
    Tan EK; Tan C; Shen H; Chai A; Lum SY; Teoh ML; Yih Y; Wong MC; Zhao Y
    Neurosci Lett; 2003 Jan; 336(1):70-2. PubMed ID: 12493604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene.
    Chiba-Falek O; Kowalak JA; Smulson ME; Nussbaum RL
    Am J Hum Genet; 2005 Mar; 76(3):478-92. PubMed ID: 15672325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype.
    Khan N; Graham E; Dixon P; Morris C; Mander A; Clayton D; Vaughan J; Quinn N; Lees A; Daniel S; Wood N; de Silva R
    Ann Neurol; 2001 May; 49(5):665-8. PubMed ID: 11357958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of alpha synuclein/ NACP polymorphism in Parkinson's disease in Japan.
    Mizuta I; Nishimura M; Mizuta E; Yamasaki S; Ohta M; Kuno S
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):350. PubMed ID: 12185186
    [No Abstract]   [Full Text] [Related]  

  • 15. Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease.
    Parsian A; Racette B; Zhang ZH; Chakraverty S; Rundle M; Goate A; Perlmutter JS
    Neurology; 1998 Dec; 51(6):1757-9. PubMed ID: 9855543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Synuclein locus triplication causes Parkinson's disease.
    Singleton AB; Farrer M; Johnson J; Singleton A; Hague S; Kachergus J; Hulihan M; Peuralinna T; Dutra A; Nussbaum R; Lincoln S; Crawley A; Hanson M; Maraganore D; Adler C; Cookson MR; Muenter M; Baptista M; Miller D; Blancato J; Hardy J; Gwinn-Hardy K
    Science; 2003 Oct; 302(5646):841. PubMed ID: 14593171
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population.
    Myhre R; Toft M; Kachergus J; Hulihan MM; Aasly JO; Klungland H; Farrer MJ
    Acta Neurol Scand; 2008 Nov; 118(5):320-7. PubMed ID: 18485051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson's disease.
    Wang CK; Chen CM; Chang CY; Chang KH; Chen IC; Li ML; Lee-Chen GJ; Wu YR
    J Neural Transm (Vienna); 2006 Oct; 113(10):1425-33. PubMed ID: 16604306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. alpha-Synuclein promoter confers susceptibility to Parkinson's disease.
    Pals P; Lincoln S; Manning J; Heckman M; Skipper L; Hulihan M; Van den Broeck M; De Pooter T; Cras P; Crook J; Van Broeckhoven C; Farrer MJ
    Ann Neurol; 2004 Oct; 56(4):591-5. PubMed ID: 15455394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic analysis of the alpha-synuclein and the parkin gene in Parkinson's disease in Finland.
    Autere JM; Hiltunen MJ; Mannermaa AJ; Jäkälä PA; Hartikainen PH; Majamaa K; Alafuzoff I; Soininen HS
    Eur J Neurol; 2002 Sep; 9(5):479-83. PubMed ID: 12220378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.